The discovery of CD44+/CD24- cells has generated excitement and led to efforts in multiple laboratories to find vulnerability for this subpopulation, as this subpopulation of cancer cells may represent a therapeutic target to anticancer drugs [10–12]. This evidence concerns the gene CD24 and cancer.